Rheumatology (May 2022)

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study

  • Marcin Stajszczyk,
  • Sławomir Jeka,
  • Anna Juś,
  • Katarzyna Pawlak-Buś

DOI
https://doi.org/10.5114/reum.2022.115986
Journal volume & issue
Vol. 60, no. 2
pp. 92 – 100

Abstract

Read online

No abstracts available.

Keywords